Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer

Abstract

This study highlights high rates of guideline-recommended first treatment among the real-world LS and ES patients but it also revealed important outcome differences in relapsed LS and ES patients treated with second-line chemotherapy.